CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-21 | Silver Brian M. Chief Financial Officer | Purchase | +5,000 | $6.32 | $32K | 11,885 |
| 2021-09-21 | MacBeath Gavin Chief Scientific Officer | Purchase | +57 | $6.19 | $353 | 49,767 |
| 2021-09-20 | MacBeath Gavin Chief Scientific Officer | Purchase | +4,943 | $6.22 | $31K | 49,710 |
| 2021-09-09 | Silver Brian M. Chief Financial Officer | Purchase | +5,885 | $8.48 | $50K | 6,885 |
| 2021-09-08 | SOUTHWELL DAVID P Chief Executive Officer | Purchase | +11,000 | $8.73 | $96K | 97,899 |
| 2021-09-07 | ZDRAVESKI ZORAN Chief Legal Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2021-08-27 | Desmarais William Chief Business Officer | Purchase | +2,500 | $9.08 | $23K | 2,500 |
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Purchase | +104,698 | $15.00 | $1.6M | 104,698 |
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Purchase | +1,320,302 | $15.00 | $19.8M | 1,320,302 |
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Conversion · Series C Convertible Preferred Stock | −315,777 | 0 | ||
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +315,777 | 315,777 | ||
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Conversion · Series C Convertible Preferred Stock | −3,960,811 | 0 | ||
| 2021-07-20 | BAKER BROS. ADVISORS LP Director | Conversion · Non-Voting Common Stock | +3,960,811 | 3,960,811 | ||
| 2021-07-20 | Westphal Christoph H 10% owner | Conversion | +1,145,505 | 1,145,505 | ||
| 2021-07-20 | Westphal Christoph H 10% owner | Purchase | +133,333 | $15.00 | $2.0M | 1,278,838 |
| 2021-07-20 | Westphal Christoph H 10% owner | Conversion · Series A Preferred Stock | −641,848 | 0 | ||
| 2021-07-20 | Westphal Christoph H 10% owner | Conversion · Series B Preferred Stock | −332,594 | 0 | ||
| 2021-07-20 | Westphal Christoph H 10% owner | Conversion · Series C Preferred Stock | −171,063 | 0 | ||
| 2021-07-20 | BARBERICH TIMOTHY J Director | Conversion | +33,259 | 33,259 | ||
| 2021-07-20 | BARBERICH TIMOTHY J Director | Conversion · Series B Preferred Stock | −33,259 | 0 |
Page 7 of 8 · 144 trades